Abbott and Pierre Fabre Target Cancer in Antibody Pact
By Taskin Ahmed
Pharma Deals Review: Vol 2010 Issue 2 (Table of Contents)
Published: 10 Feb-2010
DOI: 10.3833/pdr.v2010.i2.1312 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Abbott has bolstered its oncology pipeline by signing an exclusive worldwide licensing agreement with Pierre Fabre SA...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018